Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death
Despite the available chemotherapy and treatment, leukemia remains a difficult disease to cure due to frequent relapses after treatment. Among the heterogeneous leukemic cells, a rare population referred as the leukemic stem cell (LSC), is thought to be responsible for relapses and drug resistance....
Main Authors: | Qian Feng, Wa Seng Leong, Liang Liu, Wai-In Chan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/21/4/534 |
Similar Items
-
The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses
by: Wu, Kan Xing, et al.
Published: (2023) -
The host-targeting compound peruvoside has a broad-spectrum antiviral activity against positive-sense RNA viruses
by: Kan Xing Wu, et al.
Published: (2023-05-01) -
Cardiac Glycosides as Autophagy Modulators
by: Jan Škubník, et al.
Published: (2021-11-01) -
Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status
by: Jirarat Poohadsuan, et al.
Published: (2023-10-01) -
Transcriptome Profiling of Cardiac Glycoside Treatment Reveals EGR1 and Downstream Proteins of MAPK/ERK Signaling Pathway in Human Breast Cancer Cells
by: Honey Pavithran, et al.
Published: (2023-11-01)